APOE-ε4 is associated with memory decline in cognitively impaired elderly

Neurology

Volumn 54, Issue 7, 2000, Pages 1492-1497

  Dik, M G ^a,b   Jonker, C ^a,b   Bouter, L M ^a   Geerlings, M I ^a   Van Kamp, G J ^c   Deeg, D J H ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AD; Age; APOE; Elderly; Memory decline; Population based study

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; AGE DISTRIBUTION; ALLELE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FOLLOW UP; GENETICS; LONGITUDINAL STUDY; MEMORY DISORDER; MIDDLE AGED; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; RISK; RISK ASSESSMENT; SEX RATIO; STATISTICAL MODEL;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; MIDDLE AGED; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 0034635915     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.7.1492     Document Type: Article

References (29)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
2. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
3. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997;277:822-824.
4. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278:1349-1356.
5. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998;55: 964-968.
6. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 1999;14:295-303.
7. Caselli RJ, Graff-Radford NR, Reiman EM, et al. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon 4 homozygotes. Neurology 1999;53:201-207.
8. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 1999;100:53-60.
9. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
10. Smith GE, Bohac DL, Waring SC, et al. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-362.
11. Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer L. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998;55:1065-1069.
12. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942-947.
13. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758.
14. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the APOE-epsilon 4 allele in non-demented older adults. Neurology 1995;45:2203-2206.
15. Helkala EL, Koivisto K, Hanninen T, et al. The association of apolipoprotein E polymorphism with memory: a population based study. Neurosci Lett 1995;191:141-144.
16. Deeg DJH, Knipscheer CPM, van Tilburg W, eds. Autonomy and well-being in the aging population: concepts and design of the Longitudinal Aging Study Amsterdam. Bunnik: Netherlands Institute of Gerontology, 1993.
17. van den Heuvel N, Smits CHM, Deeg DJH, Beekman ATF. Personality: a moderator of the relation between cognitive functioning and depression in adults aged 55-85? J Affect Disord 1996;41:229-240.
18. Smit JH, de Vries MZ, Poppelaars JL. Data-collection and fieldwork procedures. In: Deeg DJH, Beekman ATF, Kriegsman DMW, Westendorp-de Serière M, eds. Autonomy and well-being in the aging population: volume II. Amsterdam: VU University Press, 1998:9-20.
19. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Rey A. L' examen clinique en psychologie. Paris: Presses Universitaire de France, 1964.
21. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term post-operative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet 1998;351:857-861.
22. Jolles J, Houx PJ, van Boxtel MPJ, Ponds RWHM, eds. Maastricht Aging Study. Determinants of cognitive aging. Maastricht: Neuropsych Publishers, 1995.
23. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987;28:455-463.
24. Kittner SJ, White LR, Farmer ME, et al. Methodological issues in screening for dementia: the problem of education adjustment. J Chron Dis 1986;39:163-170.
25. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992; 49:453-460.
26. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997;60:439-446.
27. Frisoni GB, Manfredi M, Geroldi C, et al. The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent. J Neurol Neurosurg Psychiatry 1998;65:103-106.
28. Breitner JCS, Wyse BW, Anthony JC, et al. APOE-epsilon 4 count predicts age when prevalence of AD increases, then declines - The Cache County Study. Neurology 1999;53:321-331.
29. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman B. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.